𝔖 Bobbio Scriptorium
✦   LIBER   ✦

α-Interferon treatment for idiopathic hypereosinophilic syndrome

✍ Scribed by Paula L. Bockenstedt; John T. Santinga; Steven F. Bolling

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
334 KB
Volume
45
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alpha interferon for hypereosinophilic s
Alpha interferon for hypereosinophilic syndrome
✍ Amando Blanquer; Alfonso Lopez; Fabian Tarín; Fernando Hernandez; Mariano Linare 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB 👁 1 views
2-Chlorodeoxyadenosine and cytarabine co
2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome
✍ Elias Jabbour; Srdan Verstovsek; Francis Giles; Varsha Gandhi; Jorge Cortes; Sus 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB 👁 1 views

## Abstract ## BACKGROUND Hypereosinophilic syndrome (HES) is a rare, disabling, and incurable disease. In this study, a combination of 2‐chlorodeoxyadenosine (2‐CdA) and cytosine arabinoside (ara‐C) chemotherapy was evaluated in patients with HES. ## METHODS Nine patients with HES were treated

Hypereosinophilic syndrome treated with
Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity
✍ Dr. Per Boye Hansen; Hans E. Johnsen; Erik Hippe 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

A 34-year-old male with hypereosinophilic syndrome (HES) and cardiac complications was treated with recombinant human a-interferon (rhlFN) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) in the attempt to suppress the eosinophilic cell clones and stimulate the neutrophil myelop